Nektar Therapeutics (0UNL.L)
USD 1.01
(-1.02%)
USD 1.01
(-1.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -192.6 Million | -304 Million | -412.66 Million | -313.28 Million | -328.68 Million | 718.21 Million |
| Net Income | -276.05 Million | -368.19 Million | -523.83 Million | -444.44 Million | -440.66 Million | 681.31 Million |
| Depreciation & Amortization | 7.81 Million | 13.03 Million | 14.14 Million | 14.18 Million | 13.15 Million | 10.87 Million |
| Deferred income taxes | -140 Thousand | 2.7 Million | 8.02 Million | 20.35 Million | - | - |
| Stock-based compensation | 33.38 Million | 57.32 Million | 94.67 Million | 94.26 Million | 99.79 Million | 88.1 Million |
| Change in working capital | -19.8 Million | 492 Thousand | -23.07 Million | 16.71 Million | 21.68 Million | -39 Million |
| Other non-cash items | 62.18 Million | -9.35 Million | 17.41 Million | -14.35 Million | -22.65 Million | -23.06 Million |
| Investing Cash Flow | 139.56 Million | 365.83 Million | 202.77 Million | 496.21 Million | 206.88 Million | -1.37 Billion |
| Investments in PPE | -865 Thousand | -5.67 Million | -14.98 Million | -7.25 Million | -26.28 Million | -14.23 Million |
| Acquisitions | 1.24 Million | 13.19 Million | -217.76 Million | -503.47 Million | -233.17 Million | 2.63 Million |
| Investment purchases | -511.69 Million | -467.91 Million | -960.68 Million | -987.53 Million | -1.38 Billion | -2.27 Billion |
| Sales/Maturities of investments | 650.88 Million | 826.22 Million | 1.17 Billion | 1.49 Billion | 1.61 Billion | 902.92 Million |
| Other Investing Activities | 1.24 Million | 371.51 Million | 217.76 Million | 503.47 Million | 233.17 Million | 2.63 Million |
| Financing Cash Flow | 30 Thousand | 1.5 Million | 36.23 Million | -80.35 Million | 23.35 Million | 851.96 Million |
| Debt repayment | - | - | - | -250 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 30 Thousand | 758 Thousand | 33.23 Million | 23.39 Million | 23.35 Million | 851.96 Million |
| Other Financing Activities | 30 Thousand | 750 Thousand | 3 Million | 146.25 Million | 23.35 Million | 851.96 Million |
| Accounts receivables | 4.77 Million | 16.51 Million | 12.39 Million | 1.91 Million | 6.41 Million | -25.5 Million |
| Accounts payables | -2.88 Million | 3.1 Million | -11.69 Million | 2.38 Million | 12.96 Million | 971 Thousand |
| Inventory | 699 Thousand | -3.4 Million | -509 Thousand | -2.62 Million | -1.28 Million | -655 Thousand |
| Other working capital | -22.39 Million | -15.72 Million | -23.27 Million | 15.04 Million | 3.59 Million | -13.81 Million |
| Cash at beginning of period | 66.82 Million | 25.21 Million | 198.95 Million | 96.36 Million | 194.9 Million | 4.76 Million |
| Cash at end of period | 20.16 Million | 88.22 Million | 25.21 Million | 198.95 Million | 96.36 Million | 194.9 Million |
| Capital Expenditure | -865 Thousand | -5.67 Million | -14.98 Million | -7.25 Million | -26.28 Million | -14.23 Million |
| Effect of forex changes on cash | 62 Thousand | -327 Thousand | -92 Thousand | 20 Thousand | -102 Thousand | -101 Thousand |
| Net cash flow / Change in cash | -46.66 Million | 63 Million | -173.73 Million | 102.59 Million | -98.54 Million | 190.14 Million |
| Free Cash Flow | -193.47 Million | -309.68 Million | -427.64 Million | -320.54 Million | -354.96 Million | 703.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -52.36 Million | -36.8 Million | -42.07 Million | -276.05 Million | -45.83 Million | -51.12 Million |
| Depreciation & Amortization | 1.45 Million | 1.6 Million | 1.65 Million | 7.81 Million | 1.69 Million | 2.16 Million |
| Deferred income taxes | 57 Thousand | -38 Thousand | 1.71 Million | -140 Thousand | -15 Thousand | -27 Thousand |
| Stock-based compensation | 5.41 Million | 6 Million | 7.25 Million | 33.38 Million | 8.14 Million | 7.96 Million |
| Change in working capital | 10.8 Million | -6.62 Million | -4.73 Million | -19.8 Million | -4.48 Million | -9.06 Million |
| Other non-cash items | 4.9 Million | 1.72 Million | -10.85 Million | 62.18 Million | -1.62 Million | -1.44 Million |
| Investing Cash Flow | 16.98 Million | 19.25 Million | 17.38 Million | 139.56 Million | 56.41 Million | 25.17 Million |
| Investments in PPE | -186 Thousand | -157 Thousand | -237 Thousand | -865 Thousand | -33 Thousand | -162 Thousand |
| Acquisitions | - | - | 65.11 Million | 1.24 Million | 1.24 Million | -25.33 Million |
| Investment purchases | -68.44 Million | -105.05 Million | -138.87 Million | -511.69 Million | -123.09 Million | -142.71 Million |
| Sales/Maturities of investments | 85.61 Million | 124.47 Million | 156.49 Million | 650.88 Million | 178.29 Million | 168.04 Million |
| Other Investing Activities | - | - | -65.11 Million | 1.24 Million | - | 25.33 Million |
| Financing Cash Flow | 19 Thousand | 42 Million | 12 Thousand | 30 Thousand | -64.92 Million | 18 Thousand |
| Debt repayment | - | -15 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -3 Million | - | - | - | - |
| Common Stock Issuance | 19 Thousand | 30 Million | 12 Thousand | 30 Thousand | - | 18 Thousand |
| Other Financing Activities | 19 Thousand | 15 Million | 64.95 Million | 30 Thousand | - | 18 Thousand |
| Accounts receivables | 2.42 Million | -2.41 Million | 999 Thousand | 4.77 Million | -869 Thousand | 1.66 Million |
| Accounts payables | -2.27 Million | -988 Thousand | 6.44 Million | -2.88 Million | 669 Thousand | -1.07 Million |
| Inventory | 212 Thousand | -1.14 Million | 1.07 Million | 699 Thousand | 1.11 Million | -454 Thousand |
| Other working capital | 10.44 Million | -2.07 Million | -13.24 Million | -22.39 Million | -5.4 Million | -9.18 Million |
| Cash at beginning of period | 34.74 Million | 20.16 Million | 49.73 Million | 66.82 Million | 43.22 Million | 76.95 Million |
| Cash at end of period | 13.92 Million | 34.74 Million | 20.16 Million | 20.16 Million | 49.73 Million | 50.72 Million |
| Capital Expenditure | -186 Thousand | -157 Thousand | -237 Thousand | -865 Thousand | -33 Thousand | -162 Thousand |
| Effect of forex changes on cash | -1000.00 | -8000.00 | 8000.00 | 62 Thousand | -98 Thousand | 107 Thousand |
| Net cash flow / Change in cash | -20.82 Million | 14.58 Million | -29.57 Million | -46.66 Million | 6.5 Million | -26.22 Million |
| Free Cash Flow | -37.88 Million | -48.04 Million | -47.28 Million | -193.47 Million | -42.15 Million | -51.68 Million |
HSHZY
TSFA
SMR
SMDR
601005
MRCBF